Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
BMJ
; 373: n1205, 2021 06 09.
Article
in En
| MEDLINE
| ID: mdl-34108229
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Surgical Procedures, Operative
/
Thromboembolism
/
Heart Valve Prosthesis
/
Dalteparin
/
Anticoagulants
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMJ
Journal subject:
MEDICINA
Year:
2021
Document type:
Article
Affiliation country:
Canadá